Great Deal! Get Instant $10 FREE in Account on First Order + 10% Cashback on Every Order Order Now

TUM202_Assessment_2_Brief_CaseStudy_Module 4.2 Page 1 of 6 Task Summary In this assessment, you will review the case of a patient who is on multiple medications and answer a series of short answer...

1 answer below »
TUM202_Assessment_2_Brief_CaseStudy_Module 4.2 Page 1 of 6
Task Summary
In this assessment, you will review the case of a patient who is on multiple medications and answer
a series of short answer questions related to polypharmacy (1500 words).
Please refer to the Task Instructions for details on how to complete this task.
Context
ASSESSMENT 2 BRIEF
Subject Code and Title TUM202 Therapeutic Use of Medicines.
Assessment Case Study – Polypharmacy
Individual/Group Individual
Length 1,500 words +/- 10%
Learning Outcomes The Subject Learning Outcomes demonstrated by successful
completion of the task below include:
a) Identify and discuss the general principles of pharmacology
including pharmacokinetic concepts and pharmacodynamics
and their application to pathophysiological states.
) Explain and apply quality & safety frameworks to the use of
therapeutic medicines in clinical practice
c) Compare and contrast the mechanisms of action, therapeutic
uses, adverse effects, interactions, contraindications and
outes of administration of different drug groups.
d) Deduce the factors contributing to individual variability and
determine dosage individualisation strategies to control
variability in drug response including lifespan aspects of drug
therapy and population groups with specific needs.
e) Identify and justify utilisation of evidence-based reference
esources relating to integrative pharmacology to identify,
prevent and clinically manage polypharmacy, potential
adverse drug reactions, interactions and toxicity to ensure
safe practices.
g) Explore and apply professional, legal and ethical issues
su
ounding the safe prescription and administration of
medications.
Submission Due by 11:55pm AEST Sunday end of Module 4.2 (Week 8).
Weighting 35%
Total Marks 100 marks
TUM202_Assessment_2_Brief_CaseStudy_Module 4.2 Page 2 of 6

Polypharmacy is a significant problem in the community, particularly for people living with multiple
como
idities or multiple chronic diseases. Knowledge of medications and their actions and
interactions with each other is an important skill of nursing practice. Drug-drug interactions can
have significant consequences for the patient. This task is designed to assess the theoretical
knowledge that you have acquired whilst undertaking TUM202 Therapeutic Use of Medicines.
Task Instructions
To complete this assessment task, you must:
• Read the case study document found in Assessment resources on Blackboard.
• Your response to the case study should:

o Define polypharmacy. Who is at risk of polypharmacy? What are the impacts of
polypharmacy on the older person, on the healthcare system? Introduce the case study
iefly.
o Identify the two drug- drug interactions. Which drug -drug interaction is linked to the
signs and symptoms that the case study has presented with? What is causing the
symptoms?
o Propose strategies that can be implemented to identify and prevent polypharmacy.
Identify evidence-based resources that can assist you to identify possible drug – drug
interactions?
o Consider how you could advocate for the case study with the medical officers.

Please note that a similar word count should be dedicated to each section.
Sub-headings can be used for different sections.
Referencing
It is essential that you use appropriate APA 6th ed. style for citing and referencing research.
Please see more information on referencing here
http:
li
ary.laureate.net.au
esearch_skills
eferencing
Submission Instructions
Please submit your Case Evaluation word document into Assessment 3 submission link in
the Assessment section found in the main navigation menu of the subject TUM202
Blackboard site. A ru
ic will be attached to the assessment. The Learning Facilitator will
provide feedback via the Grade Centre in the LMS portal. Feedback can be viewed in My
Grades.
http:
li
ary.laureate.net.au
esearch_skills
eferencing

TUM202_Assessment_2_Brief_CaseStudy_Module_4.2 Page 3 of 6
Assessment Ru
ic: Case study - Polypharmacy
Assessment
Attributes
Fail
(Yet to achieve
minimum standard)
0-49%
Pass
(Functional)
50-64%
Credit
(Proficient)
65-74%
Distinction
(Advanced)
75-84%
High Distinction
(Exceptional)
85-100%

Knowledge and
understanding of
polypharmacy and its
implications for the
patient




30%



Incomplete understanding
of polypharmacy and its
implications for the
patient.

Does not accurately
describe the impacts of
polypharmacy on the
patient.

Unable to identify which
drug – drug interaction is
causing the patients
symptoms


Demonstrates a functional
knowledge of polypharmacy:

Limited description of
polypharmacy, No key
elements of polypharmacy
identified.

Partial identification of the
drug – drug interaction.







Demonstrates proficient
knowledge of
polypharmacy:

Provides a satisfactory
description of
polypharmacy but missing
multiple key elements.

Identifies the drug – drug
interaction but no linking of
the signs and symptoms to
the drug interaction.



Demonstrates advanced
knowledge of
polypharmacy by

Provides a thorough
description of
polypharmacy but missing
one or two key elements.

Identifies the drug- drug
interaction but unclear
linking of signs and
symptoms to the drug
interaction.


Demonstrates exceptional
knowledge of
polypharmacy.

Provides excellent
description on the impacts
of polypharmacy on a
patient.

Clearly identifies the drug –
drug interaction that is
occu
ing in the case study,
linking the signs and
symptoms to the drug
interaction.

Analysis and
application with
synthesis of new
knowledge

Analysis of
polypharmacy and its
identification and
prevention

Limited synthesis and
analysis of topic.

Limited ability to identify
strategies to prevent poly
pharmacy and how the
nurse may advocate for
patients.


Functional synthesis and
analysis of topic.

Some ability to identify
strategies to prevent poly
pharmacy and/or limited
identification of the nurses’
ole in advocating for the
patient,

Well-developed analysis
and synthesis of the topic.

Clearly identifies strategies
to prevent poly pharmacy
ut offers some reflection
on the nurses’ role in
advocating for the patient.


Thoroughly developed and
creative analysis and
synthesis of the topic.

Thorough identification of
strategies to prevent
polypharmacy,


Highly developed and
critical analysis, of the
information pertaining to
the topic.

Excellent identification of
strategies to prevent
polypharmacy.
TUM202_Assessment_2_Brief_CaseStudy_Module_4.2 Page 4 of 6



25%

Confuses logic and
emotion. Information
taken from reliable
sources but without a
coherent analysis or
synthesis.

Viewpoints of experts are
taken as fact with little
questioning.


Limited understanding of
key concepts required to
support the case study.


Often conflates/confuses
assertion of personal opinion
with information
substantiated by evidence
from the research/course
materials.


Analysis and evaluation do
not reflect expert judgement,
intellectual independence,
igor and adaptability.


Resembles a recall or
summary of key ideas.




Demonstrates a capacity to
explain and apply relevant
concepts.

Identifies logical flaws.

Questions viewpoints of
experts.


Supports personal opinion
and information
substantiated by evidence
from the research/course
materials.



Identifies the nurses’ role in
advocating for the patient
ut is unable to provide in
depth detail on advocacy
ole.

Well demonstrated capacity
to explain and apply
elevant concepts.

Viewpoint of experts are
subject to questioning.

Analysis and evaluation
eflect growing judgement,
intellectual independence,
igor and adaptability.

Discriminates between
assertion of personal
opinion and information
substantiated by robust
evidence from the
esearch/course materials
and extended reading.

Identifies the nurses’ role
as an advocate for the
patient and clearly
describes the role of the
nurse.

Information is taken from
sources with a high level of
interpretation/evaluation
to develop a
comprehensive critical
analysis or synthesis.

Identifies gaps in
knowledge.

Exhibits intellectual
independence, rigor, good
judgement and
adaptability.

Systematically and critically
discriminates between
assertion of personal
opinion and information
substantiated by robust
evidence from the
esearch/course materials
and extended reading.


Breadth and depth of
esearch and the use of
esources





Demonstrates
inconsistent use of good
quality, credible and



Demonstrates use of credible
and relevant resources to
support and develop ideas,



Demonstrates use of
credible resources to
support and develop ideas.


Demonstrates use of good
quality, credible and
elevant resources to


Demonstrates use of high-
quality, credible and
elevant resources to
support and develop
TUM202_Assessment_2_Brief_CaseStudy_Module_4.2 Page 5 of 6

25%

elevant resources to
support and develop
ideas.





ut these are not always
explicit or well developed












support and develop
arguments and statements.

Show evidence of wide
scope within the
organisation for sourcing
evidence.

arguments and position
statements.

Show evidence of wide
scope within and without
the organisation for
sourcing evidence.


Effective
Communication
(Written)


10%

Poor presentation of
information.


Meaning is repeatedly
Answered Same Day Apr 08, 2021 TUM202 Torrens University Australia

Solution

Preeti answered on Apr 10 2021
158 Votes
Running Head: NURSING
Health Care
1) Define Polypharmacy. Who is at risk of Polypharmacy? What are the impacts of Polypharmacy on the older person, on the healthcare system? Introduce the case study
Briefly
The case study is based on an old lady named Gladys who is cu
ently suffering from Polypharmacy, a multiple chronic diseases. As diagnosed by her community carer, old age lady is being admitted in the hospital on account of difficulty in mobilising body, jerking on legs, unusual sweating and back pain. The old age lady is diagnosed with Polypharmacy, which is understood as the concu
ent use and consumption of different kinds of medications by a patient. The simultaneous use of multiple medicines or drugs for treating a single ailment or condition is understood as Polypharmacy. Even though, there is no standardised limit or threshold defining the term ‘multiple medications’, still, a threshold of at least five medications is commonly accepted.
Following this criteria, Centers for Disease Control and Prevention (CDC) estimated that Polypharmacy occurs in older adults around 20% to 30% as older adults are found as taking at least four prescription or medications daily (Edlin, 2017). It is found as higher in old age populations suffering from multiple chronic diseases and greater frailty. In many instances, it is found that Polypharmacy create negative impact on patients, and, results in poor treatment effectiveness. Health professionals consider Polypharmacy as a situation that requires constant monitoring and review for validating whether all the medications prescribed to the patients are necessary and crucial (Saljoughian, 2019).
One article published by US Pharmacist.com have shown that people over 65 years are taking around five or more medications, this proportion is increased from 53.4% to 67.1% between 2006 and 2011 (Saljoughian, 2019). Polypharmacy becomes problematic when patient is not clear with the reason for medication, dosage and timing are complicated, and, when medicines interact with each other. With respect to old age person, Polypharmacy leads to decreased functionality, higher chances of fall/fractures, hospitalisations, reduced mobility and cognition. The risk factor for older people is high as their body react differently to medications, as compared to younger patients. In old-age, body fat increases and total body water composition decreases. These physical changes result in higher concentration of water –soluble drugs and fat-soluble medications, which ultimately reduces blood flow and liver metabolism rate. All these physical changes and alterations make old age people body vulnerable to several chronic diseases. With the aging population and its continuous growth, healthcare system is also challenged with the increasing burden of chronic diseases and rising expenditures on medical prescriptions (Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988–2010).
2) Identify the two drug- drug interactions. Which drug -drug interaction is linked to the signs and symptoms that the case study has presented with? What is causing the
Symptoms?
A medication presumed not to work as well when used along with other medications, results in interference of effect, is termed as drug-drug interaction. When a medication is used to treat a disease or symptom, it might cause negative effect on another disease and symptom. In the given case scenario, patient is suffering from several chronic diseases, such as hypertension, depression, Osteoarthritis, deaf, back pain and many more.
For this, she is taking more than seven medications daily, therefore living at high risk of drug-drug interactions. Some are inflammatory medications used as pain-killers, which might increase blood pressure and worsen kidney function, in this way, curing one disease, but, at the same time, giving rise to new one. Health Research Funding Reports stated that more drugs, higher are the chances and...
SOLUTION.PDF

Answer To This Question Is Available To Download

Related Questions & Answers

More Questions »

Submit New Assignment

Copy and Paste Your Assignment Here